tolbutamide has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angus, JA; Cocks, TM; King, SJ | 1 |
| Callingham, BA; Crosbie, AE; Latimer, RD; Ritchie, AJ; Vuylsteke, A | 1 |
2 other study(ies) available for tolbutamide and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Vessels; Dogs; Endothelins; Endothelium, Vascular; Female; Glyburide; In Vitro Techniques; Isometric Contraction; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Peptides; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Tolbutamide | 1990 |
Inhibitory effects of glibenclamide on the contraction of human arterial conduits used in coronary artery bypass surgery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Calcium; Coronary Artery Bypass; Dose-Response Relationship, Drug; Glyburide; Humans; In Vitro Techniques; Indomethacin; Mammary Arteries; Phenylephrine; Potassium; Radial Artery; Tolbutamide; Vasoconstriction; Vasoconstrictor Agents | 2000 |